The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy

PURPOSE: Neoadjuvant chemoradiotherapy (nCRT) is a standard treatment option for patients with stage III oesophageal cancer. Approximately 30% of oesophageal cancer patients will have a pathological complete response (pCR) after nCRT. However, available clinical methods cannot accurately predict pCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jin, Lin, Hai-Ping, Xu, Xin, Wang, Xiao-Hang, Rong, Ling, Zhang, Yao, Shen, Lei, Xu, Lei, Qin, Wei-Ting, Ye, Qing, Ma, Xiu-Mei, Bai, Yong-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701713/
https://www.ncbi.nlm.nih.gov/pubmed/36451825
http://dx.doi.org/10.3389/fimmu.2022.1041126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701713/
https://www.ncbi.nlm.nih.gov/pubmed/36451825
http://dx.doi.org/10.3389/fimmu.2022.1041126

Ejemplares similares